{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:41:57Z","timestamp":1791985317262,"version":"4.4.0"},"publisher-location":"Berlin, Heidelberg","reference-count":26,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642257605","type":"print"},{"value":"9783642257612","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-25761-2_5","type":"book-chapter","created":{"date-parts":[[2012,11,5]],"date-time":"2012-11-05T12:42:29Z","timestamp":1352119349000},"page":"125-134","source":"Crossref","is-referenced-by-count":11,"title":["Managing the Prodrome of Schizophrenia"],"prefix":"10.1007","author":[{"given":"W. Wolfgang","family":"Fleischhacker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Simma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,28]]},"reference":[{"issue":"1","key":"5_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.schres.2010.10.015","volume":"125","author":"J Addington","year":"2011","unstructured":"Addington J, Epstein I, Liu L, French P, Boydell K, Zipursky RB (2011a) A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res 125(1):54\u201361","journal-title":"Schizophr Res"},{"issue":"8","key":"5_CR2","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1176\/appi.ajp.2011.10081191","volume":"168","author":"J Addington","year":"2011","unstructured":"Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R (2011b) At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry 168(8):800\u2013805","journal-title":"Am J Psychiatry"},{"issue":"2","key":"5_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","volume":"67","author":"G Amminger","year":"2010","unstructured":"Amminger G, Sch\u00e4fer M, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE (2010) Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 67(2):146\u2013154","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"5_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1751-7893.2007.00013.x","volume":"1","author":"A Bechdolf","year":"2007","unstructured":"Bechdolf A, Wagner M, Veith V, Ruhrmann S, Pukrop R, Brockhaus-Dumke A, Berning J, Stamm E, Janssen B, Decker P, Bottlender R, M\u00f6ller HJ, Gaebel W, Maier W, Klosterk\u00f6tter J (2007) Randomized controlled multicentre trial of cognitive behaviour therapy in the early initial prodromal state: effects on social adjustment post treatment. Early Interv Psychiatry 1(1):71\u201378","journal-title":"Early Interv Psychiatry"},{"issue":"1","key":"5_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1192\/bjp.bp.109.066357","volume":"200","author":"A Bechdolf","year":"2012","unstructured":"Bechdolf A, Wagner M, Ruhrmann S, Harrigan S, Putzfeld V, Pukrop R, Brockhaus-Dumke A, Berning J, Janssen B, Decker P, Bottlender R, Maurer K, M\u00f6ller H-J, Gaebel W, H\u00e4fner H, Maier W, Klosterk\u00f6tter J (2012) Preventing progression to first-episode psychosis in early initial prodromal states. Br J Psychiatry 200(1):22\u201329","journal-title":"Br J Psychiatry"},{"issue":"10","key":"5_CR6","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1038\/sj.npp.1301628","volume":"33","author":"GE Berger","year":"2008","unstructured":"Berger GE, Wood SJ, Wellard RM, Proffitt TM, McConchie M, Amminger GP, Jackson GD, Velakoulis D, Pantelis C, McGorry PD (2008) Ethyl-eicosapentaenoic acid in first-episode psychosis: a 1H-MRS study. Neuropsychopharmacology 33(10):2467\u20132473","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"5_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.4088\/JCP.v68n0410","volume":"68","author":"BA Cornblatt","year":"2007","unstructured":"Cornblatt BA, Lencz T, Smith CW, Olsen R, Auther AM, Nakayama E, Lesser ML, Tai JY, Shah MR, Foley CA, Kane JM, Correll CU (2007) Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry 68(4):546\u2013557","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"5_CR8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1017\/S1092852900000079","volume":"15","author":"B Dell\u2019osso","year":"2010","unstructured":"Dell\u2019osso B, Altamura AC (2010) Duration of untreated psychosis and duration of untreated illness: new vistas. CNS Spectr 15(4):238\u2013246","journal-title":"CNS Spectr"},{"issue":"1","key":"5_CR9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0006-3223(99)00092-X","volume":"47","author":"WS Fenton","year":"2000","unstructured":"Fenton WS, Hibbeln J, Knable M (2000) Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiatry 47(1):8\u201321","journal-title":"Biol Psychiatry"},{"issue":"3","key":"5_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2011.1472","volume":"69","author":"P Fusar-Poli","year":"2012","unstructured":"Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, Barale F, Caverzasi E, McGuire P (2012) Predecting psychosis: meta-analysis of transition outcomes in individuals in high clinical risk. Arch Gen Psychiatry 69(3):220\u2013229","journal-title":"Arch Gen Psychiatry"},{"issue":"2\u20133","key":"5_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000284224","volume":"18","author":"G Gross","year":"1985","unstructured":"Gross G, Huber G (1985) Psychopathology of basic stages of schizophrenia in view of formal thought disturbances. Psychopathology 18(2\u20133):115\u2013125","journal-title":"Psychopathology"},{"issue":"12","key":"5_CR12","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1176\/appi.ajp.2011.11010160","volume":"168","author":"OD Howes","year":"2011","unstructured":"Howes OD, Bose SK, Turkheimer F, Valli I, Egerton A, Valmaggia LR, Murray RM, McGuire P (2011) Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry 168(12):1311\u20131317","journal-title":"Am J Psychiatry"},{"key":"5_CR13","doi-asserted-by":"crossref","unstructured":"Koutsouleris N, Borgwardt S, Meisenzahl EM, Bottlender R, M\u00f6ller HJ, Riecher-R\u00f6ssler A (2011) Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study. Schizophr Bull, 10 (Schizophr Bull first published online 2011 November 10), doi: 10.1093\/schbul\/sbr145","DOI":"10.1093\/schbul\/sbr145"},{"issue":"1","key":"5_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.schres.2010.09.021","volume":"125","author":"AK Malla","year":"2011","unstructured":"Malla AK, Bodnar M, Joober R, Lepage M (2011) Duration of untreated psychosis is associated with orbital-frontal grey matter volume reductions in first episode psychosis. Schizophr Res 125(1):13\u201320","journal-title":"Schizophr Res"},{"issue":"5","key":"5_CR15","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1176\/appi.ajp.163.5.790","volume":"163","author":"TH McGlashan","year":"2006","unstructured":"McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, Hawkins KA, Hoffman RE, Preda A, Epstein I, Addington D, Lindborg S, Trzaskoma Q, Tohen M, Breier A (2006) Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 163(5):790\u2013799","journal-title":"Am J Psychiatry"},{"issue":"10","key":"5_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/archpsyc.59.10.921","volume":"59","author":"PD McGorry","year":"2002","unstructured":"McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H (2002) Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 59(10):921\u2013928","journal-title":"Arch Gen Psychiatry"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1192\/bjp.185.4.291","volume":"185","author":"AP Morrison","year":"2004","unstructured":"Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, Parkers S, Bentall RP (2004) Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial. Br J Psychiatry 185:291\u2013297","journal-title":"Br J Psychiatry"},{"issue":"3","key":"5_CR18","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/schbul\/sbl042","volume":"33","author":"AP Morrison","year":"2007","unstructured":"Morrison AP, French P, Parker S, Roberts M, Stevens H, Bentall RP, Lewis SW (2007) Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. Schizophr Bull 33(3):682\u2013687","journal-title":"Schizophr Bull"},{"issue":"1","key":"5_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.schres.2006.01.002","volume":"83","author":"M Nordentoft","year":"2006","unstructured":"Nordentoft M, Thorup A, Petersen L, Ohlenschlaeger J, Melau M, Christensen T\u00d8, Krarup G, J\u00f8rgensen P, Jeppesen P (2006) Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment. Schizophr Res 83(1):29\u201340","journal-title":"Schizophr Res"},{"issue":"1\u20133","key":"5_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.schres.2007.05.018","volume":"96","author":"LJ Phillips","year":"2007","unstructured":"Phillips LJ, McGorry PD, Yuen HP, Ward J, Donovan K, Kelly D, Francey SM, Yung AR (2007) Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr Res 96(1\u20133):25\u201333","journal-title":"Schizophr Res"},{"issue":"6340","key":"5_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/353164a0","volume":"353","author":"D Piomelli","year":"1991","unstructured":"Piomelli D, Pilon C, Giros B, Sokoloff P, Martres MP, Schwartz JC (1991) Dopamine activation of the arachidonic acid cascade as a basis for D1\/D2 receptor synergism. Nature 353(6340):164\u2013167","journal-title":"Nature"},{"issue":"Suppl 3","key":"5_CR22","first-page":"S162","volume":"36","author":"S Ruhrmann","year":"2003","unstructured":"Ruhrmann S, Schultze-Lutter F, Klosterk\u00f6tter J (2003) Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry 36(Suppl 3):S162\u2013S167","journal-title":"Pharmacopsychiatry"},{"issue":"51","key":"5_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1192\/bjp.191.51.s88","volume":"191","author":"S Ruhrmann","year":"2007","unstructured":"Ruhrmann S, Bechdolf A, K\u00fchn K-U, Wagner M, Schultze-Lutter F, Janssen B, Maurer K, H\u00e4fner H, Gaebel W, M\u00f6ller HJ, Maier W, Klosterk\u00f6tter J; LIPS study group (2007) Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis. Br J Psychiatry 191(51):88\u201395","journal-title":"Br J Psychiatry"},{"key":"5_CR24","unstructured":"World Health Organisation (2001) World Health Report 2001\u2014Mental health: new understanding, new hope. Geneva"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0920-9964(03)00192-0","volume":"67","author":"AR Yung","year":"2004","unstructured":"Yung AR, Phillips LJ, Yuen HP, McGorry PD (2004) Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 67:131\u2013142","journal-title":"Schizophr Res"},{"issue":"4","key":"5_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4088\/JCP.08m04979ora","volume":"72","author":"AR Yung","year":"2011","unstructured":"Yung AR, Phillips LJ, Nelson B, Francey SM, PanYuen H, Simmons M, Ross ML, Kelly D, Baker K, Amminger GP, Berger G, Thompson AD, Thampi A, McGorry PD (2011) Randomized controlled trial of interventions for young people at ultra high risk for psychosis. J Clin Psychiatry 72(4):430\u2013440","journal-title":"J Clin Psychiatry"}],"container-title":["Handbook of Experimental Pharmacology","Current Antipsychotics"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-25761-2_5.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T12:02:19Z","timestamp":1620043339000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-25761-2_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783642257605","9783642257612"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-25761-2_5","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}